Join
Live feed
·
INSIDERFilingvia Quantisnow
Spero Therapeutics Inc. logo

Shukla Sath was granted 679,501 shares and sold $107,719 worth of shares (75,994 units at $1.42), increasing direct ownership by 105% to 1,176,007 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRO (Spero Therapeutics Inc.) and more on Quantisnow.